Julien Samson, vice president and general manager of GSK Korea explains how GSK’s new global strategy is being delivered within the Korean affiliate. Mr Samson explains the focus areas for GSK - vaccines, HIV and respiratory treatments, and provides an insight into how GSK can best utilize Korea’s strong environment for clinical research.
Korea has an amazing healthcare system and the environment is positive for pharma, with sustained five percent annual growth for the industry. There is also an ambition from the government to reinforce access to new medical devices and drugs
